(Q40707311)

22 September 2017

1 reference

title

Pharmacotherapy of chronic pulmonary arterial hypertension: value and limitations. Part II: Secondary pulmonary hypertension (English)

1 reference

22 September 2017

0 references

M A Alpert

1

1 reference

22 September 2017

M D Concannon

series ordinal

2

1 reference

22 September 2017

B Mukerji

series ordinal

3

1 reference

22 September 2017

V Mukerji

series ordinal

4

1 reference

22 September 2017

publication date

1 September 1994

1 reference

22 September 2017

1 reference

22 September 2017

volume

45

1 reference

22 September 2017

issue

9

1 reference

22 September 2017

page(s)

755-761

1 reference

Pulmonary vascular changes in scleroderma

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F000331979404500902

Hypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979404500902

The pulmonary pathologic manifestations of the CREST syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979404500902

Cardiovascular manifestations of mixed connective tissue disease in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979404500902

Sustained benefit of verapamil in pulmonary hypertension with progressive systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979404500902

Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979404500902

Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979404500902

Daily Requirement of Oxygen to Reverse Pulmonary Hypertension in Patients with Chronic Bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979404500902

Reversal of Pulmonary Hypertension by Prolonged Oxygen Administration to Patients with Chronic Bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979404500902

Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979404500902

Effects of captopril combined with oxygen therapy at rest and on exercise in patients with chronic bronchitis and pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979404500902

Short- and long-term hemodynamic effects of oral nifedipine in patients with pulmonary hypertension secondary to COPD and lung fibrosis. Deleterious effects in patients with restrictive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979404500902

Pulmonary vasodilation with prostacyclin in primary and secondary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979404500902

10.1177/000331979404500902

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference